156 related articles for article (PubMed ID: 36835452)
1. Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population.
Morales-Pison S; Morales-González S; Fernandez-Ramires R; Tapia JC; Maldonado E; Calaf GM; Jara L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835452
[TBL] [Abstract][Full Text] [Related]
2. Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
Neidhardt G; Hauke J; Ramser J; Groß E; Gehrig A; Müller CR; Kahlert AK; Hackmann K; Honisch E; Niederacher D; Heilmann-Heimbach S; Franke A; Lieb W; Thiele H; Altmüller J; Nürnberg P; Klaschik K; Ernst C; Ditsch N; Jessen F; Ramirez A; Wappenschmidt B; Engel C; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
JAMA Oncol; 2017 Sep; 3(9):1245-1248. PubMed ID: 28033443
[TBL] [Abstract][Full Text] [Related]
3. Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
Leyton Y; Gonzalez-Hormazabal P; Blanco R; Bravo T; Fernandez-Ramires R; Morales S; Landeros N; Reyes JM; Peralta O; Tapia JC; Gomez F; Waugh E; Ibañez G; Pakomio J; Grau G; Jara L
BMC Cancer; 2015 Jan; 15():30. PubMed ID: 25636233
[TBL] [Abstract][Full Text] [Related]
4. A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy.
Silvestri V; Rizzolo P; Zelli V; Valentini V; Zanna I; Bianchi S; Tibiletti MG; Varesco L; Russo A; Tommasi S; Coppa A; Capalbo C; Calistri D; Viel A; Cortesi L; Manoukian S; Bonanni B; Montagna M; Palli D; Radice P; Peterlongo P; Ottini L
Breast; 2018 Apr; 38():92-97. PubMed ID: 29287190
[TBL] [Abstract][Full Text] [Related]
5. FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
Kiiski JI; Tervasmäki A; Pelttari LM; Khan S; Mantere T; Pylkäs K; Mannermaa A; Tengström M; Kvist A; Borg Å; Kosma VM; Kallioniemi A; Schleutker J; Bützow R; Blomqvist C; Aittomäki K; Winqvist R; Nevanlinna H
Breast Cancer Res Treat; 2017 Nov; 166(1):217-226. PubMed ID: 28702895
[TBL] [Abstract][Full Text] [Related]
6. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Peterlongo P; Catucci I; Colombo M; Caleca L; Mucaki E; Bogliolo M; Marin M; Damiola F; Bernard L; Pensotti V; Volorio S; Dall'Olio V; Meindl A; Bartram C; Sutter C; Surowy H; Sornin V; Dondon MG; Eon-Marchais S; Stoppa-Lyonnet D; Andrieu N; Sinilnikova OM; ; Mitchell G; James PA; Thompson E; ; ; Marchetti M; Verzeroli C; Tartari C; Capone GL; Putignano AL; Genuardi M; Medici V; Marchi I; Federico M; Tognazzo S; Matricardi L; Agata S; Dolcetti R; Della Puppa L; Cini G; Gismondi V; Viassolo V; Perfumo C; Mencarelli MA; Baldassarri M; Peissel B; Roversi G; Silvestri V; Rizzolo P; Spina F; Vivanet C; Tibiletti MG; Caligo MA; Gambino G; Tommasi S; Pilato B; Tondini C; Corna C; Bonanni B; Barile M; Osorio A; Benitez J; Balestrino L; Ottini L; Manoukian S; Pierotti MA; Renieri A; Varesco L; Couch FJ; Wang X; Devilee P; Hilbers FS; van Asperen CJ; Viel A; Montagna M; Cortesi L; Diez O; Balmaña J; Hauke J; Schmutzler RK; Papi L; Pujana MA; Lázaro C; Falanga A; Offit K; Vijai J; Campbell I; Burwinkel B; Kvist A; Ehrencrona H; Mazoyer S; Pizzamiglio S; Verderio P; Surralles J; Rogan PK; Radice P
Hum Mol Genet; 2015 Sep; 24(18):5345-55. PubMed ID: 26130695
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.
Morales S; Gulppi F; Gonzalez-Hormazabal P; Fernandez-Ramires R; Bravo T; Reyes JM; Gomez F; Waugh E; Jara L
BMC Genet; 2016 Jul; 17(1):109. PubMed ID: 27421647
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
9. Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia.
Kasak L; Punab M; Nagirnaja L; Grigorova M; Minajeva A; Lopes AM; Punab AM; Aston KI; Carvalho F; Laasik E; Smith LB; ; Conrad DF; Laan M
Am J Hum Genet; 2018 Aug; 103(2):200-212. PubMed ID: 30075111
[TBL] [Abstract][Full Text] [Related]
10. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
[TBL] [Abstract][Full Text] [Related]
13. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Kiiski JI; Pelttari LM; Khan S; Freysteinsdottir ES; Reynisdottir I; Hart SN; Shimelis H; Vilske S; Kallioniemi A; Schleutker J; Leminen A; Bützow R; Blomqvist C; Barkardottir RB; Couch FJ; Aittomäki K; Nevanlinna H
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15172-7. PubMed ID: 25288723
[TBL] [Abstract][Full Text] [Related]
15. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
Rashid MU; Muhammad N; Shehzad U; Khan FA; Loya A; Hamann U
Fam Cancer; 2023 Jan; 22(1):31-41. PubMed ID: 35802266
[TBL] [Abstract][Full Text] [Related]
17. FANCM c5791C>T stopgain mutation (rs144567652) is a familial colorectal cancer risk factor.
Cannon-Albright LA; Teerlink CC; Stevens J; Snow AK; Thompson BA; Bell R; Nguyen KN; Sargent NR; Kohlmann WK; Neklason DW; Tavtigian SV
Mol Genet Genomic Med; 2020 Dec; 8(12):e1532. PubMed ID: 33118316
[TBL] [Abstract][Full Text] [Related]
18. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
19. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
20. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Jara L; Morales S; de Mayo T; Gonzalez-Hormazabal P; Carrasco V; Godoy R
Biol Res; 2017 Oct; 50(1):35. PubMed ID: 28985766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
